The reverse stock split will become effective at pm Eastern Time on February 13, , after close of trading on The Nasdaq Capital Market. Precision BioSciences (DTIL) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Find the latest Precision BioSciences Inc (DTIL) stock forecast, month price target, predictions and analyst recommendations. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. Precision BioSciences (DTIL) Tops Q2 Earnings and Revenue Estimates. Precision BioSciences (DTIL) delivered earnings and revenue surprises of % and
Precision BioSciences, Inc. (eventexp.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Precision BioSciences. Track Precision Biosciences Inc (DTIL) Stock Price, Quote, latest community messages, chart, news and other stock related information. 44 minutes ago. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Precision Biosciences's market cap is calculated. The reverse stock split will become effective at pm Eastern Time on February 13, , after close of trading on The Nasdaq Capital Market. Precision BioSciences Announces Closing of Underwritten Offering of Common Stock · $ per share, for total gross proceeds of approximately · $50 million. DTIL | Complete Precision Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the. Discover real-time Precision BioSciences, Inc. Common Stock (DTIL) stock prices, quotes, historical data, news, and Insights for informed trading and. Find the latest analyst research, reports, and ratings for Precision BioSciences, Inc. Common Stock (DTIL) at eventexp.ru
Precision BioSciences, Inc., an advanced gene editing company, develops in vivo gene editing therapies for gene edits, including gene elimination, insertion. Precision BioSciences Announces $ Million Offering of Common Stock and Warrants Precision BioSciences to Effect a Reverse Stock Split. January 9, Precision BioSciences, Inc. (Nasdaq: DTIL), is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS®. Precision BioSciences Inc. ; Open. ; High. ; 52wk High. ; Volume. k ; Beta. Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. Moleculin Biotech Inc. $ MBRX % ; Medicinova Inc. $ MNOV % ; Crispr Therapeutics AG. $ CRSP %. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Precision BioSciences Inc DTIL:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date02/29/24 · 52 Week Low. Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies.
Precision BioSciences, Inc., an advanced gene editing company, develops in vivo gene editing therapies for gene edits, including gene elimination, insertion. 49 minutes ago. Precision Biosciences Inc. ; Average Target Price, ; Number Of Ratings, 5 ; FY Report Date, 12/ ; Last Quarter's Earnings, ; Year Ago Earnings, Looking to buy Precision Biosciences Stock? View today's DTIL stock price, trade commission-free, and discuss DTIL stock updates with the investor. Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome Show More. Compare.